We measured the in vitro protein-tyrosine kinase activity of pp60C-" from human colon carcinoma cell lines and tumors. The activity of pp6O¢-'Cl from six of nine carcinoma cell lines was higher (on average, fivefold as measured by enolase phosphorylation, or eightfold as measured by autophosphorylation) than that of pp6OC" from normal colonic mucosal cells, or human or rodent fibroblasts. Similarly, the activity of pp60Cc from 13 of 21 primary colon carcinomas was five-or sevenfold higher than that of pp60-n? from normal colonic mucosa adjacent to the tumor. The increased pp6Ocr activity did not result solely from an increase in the level of pp60'C" protein, suggesting the specific activity of the pp6OC`SC kinase is elevated in the tumor cells. pp60oC from colon carcinoma cells and normal colonic mucosal cells was phosphorylated at similar sites. We used immunoblotting with antibodies to phosphotyrosine to identify substrates of protein-tyrosine kinases in colonic cells. Three phosphotyrosine-containing proteins were detected at significantly higher levels in most colon carcinoma cell lines than in normal colonic mucosal cells or human or rat fibroblasts. All colon carcinoma cell lines with elevated pp60C4DC in vitro kinase activity, showed increased phosphorylation of proteins on tyrosine in vivo, suggesting the presence of an activated protein-tyrosine kinase(s).
Introduction
Multiple genetic alterations appear to contribute to the malignant transformation of colonic mucosa. Allelic deletions of chromosome 5, 17 , and 18 sequences have been identified in human colon carcinomas and adenomas (1) (2) (3) (4) (5) (6) (7) (8) , suggesting that tumor suppressor genes may be important regulators of cell growth. In addition, activated protooncogenes have been identified in colonic tumors, and may be involved in molecular events leading to malignant transformation of colonic epithelial cells. Transforming ras genes (primarily c-K-ras) have been detected by gene transfer experiments in the DNA of -20% of colon carcinomas (9) (10) (11) (12) . Moreover, using DNA hybridization or RNAse A mismatch cleavage analyses, specific point mutations at position 12 (12, 13) and in five colon carcinoma cell lines (14) (15) (16) (17) (18) . Several other altered protooncogenes have also been identified in colon carcinomas. For example, amplified, overexpressed and/or rearranged c-myc (19) (20) (21) (22) (23) (24) (25) or c-myb genes (26) have been observed in some colon tumors and cell lines. Recently the lkk protein-tyrosine kinase gene (previously expressed only in tissues of lymphoid lineage) was shown to be expressed in some human colon carcinoma cell lines (27) . However, a consistent or unifying pattern of activation ofthese altered protooncogenes has not been seen, there is no evidence that they are directly responsible for tumorigenesis, and none is present in the majority of colon carcinomas. Clearly, events in addition to the activation of these cellular genes are important to the genesis of colon carcinoma. Recent observations suggest that activation of another cellular gene, c-src, may be one of these events.
The protooncogene c-src is the cellular homologue of the Rous sarcoma virus transforming gene, v-src. Both c-src and v-src encode 60-kD, membrane-associated, protein-tyrosine kinases. The transforming ability ofthe viral protein (pp60ovsrc) or of mutants of the cellular protein (pp6Ocsrc) is closely correlated with elevated specific activity of the enzyme (for review see references 28 and 29) . All transforming mutants ofpp60csrc tested have higher specific activity than normal pp6Oc-src (30) (31) (32) (33) (34) (35) (36) (37) . Bolen et al. (38) reported that the in vitro protein-tyrosine kinase activity of pp6Oc-src is elevated in many human tumors including colon carcinomas, breast adenocarcinomas (39) , rhabdomyosarcomas, and neuroblastomas (40) . The most consistent and striking elevation in pp60-src activity was observed in colon carcinoma cell lines and tumors.
We also measured the in vitro protein kinase activity of pp60ocsrc from human colon carcinoma cell lines and tumors.
Our results showed that pp60csrc from many colon carcinoma cell lines and tumors had elevated activity. However, we observed a less dramatic increase in activity in carcinoma cell lines than has been reported, and no increase in one-third of the colon carcinoma cell lines and tumors analyzed. In contrast, Bolen et al. reported enhanced pp60-src activity in all colon carcinoma cell lines and tumors tested (38) . We extended these in vitro studies by analyzing proteins phosphorylated on tyrosine in vivo in colonic cells. All colon carcinoma cell lines with elevated pp60src in vitro kinase activity showed higher levels of proteins phosphorylated on tyrosine in vivo than did normal colonic mucosal cells. Immunoblotting with antibodies to phosphotyrosine (49) . 107 cells growing on 9-cm dishes were washed twice with 10 mlof 50 mM Tris, pH 7.4; 140 mM NaCl; 3.3 mM KCI. 1 ml ofprotein sample buffer (5 mM sodium phosphate, pH 6.8; 2% SDS; 0.1 M DTT; 5% 2-mercaptoethanol; 10% glycerol; 0.4% bromophenol blue) at 100IC was added. The plate was swirled at an angle of45°until the viscous cell lysate was completely free from the surface ofthe dish. The sample was boiled for 5 min, sheared 10 times through a 22-gauge needle, 10 times through a 27-gauge needle, and stored at -70'C before use. Immunoblotting was performed as described (50) . The To determine whether the differences bbserved in pp60csrc kinase activity were due to differences in amount of pp60Csrc protein and/or to changes in the specific activity of the enzyme, pp60(src protein levels were measured by immunoblot analysis (Fig. 2) . Two proteins were detected in each lane. The upper protein is pp6&)src, the lower is the MAb 327 heavy chain (47) . The level of immunoprecipitable pp6011 in normal colonic mucosal cells (HCMC) was similar to the level in human (FLOW 2000) or rat (208F) fibroblasts. The amount of pp60SrC protein in the colon carcinoma cell lines varied, but was generally higher than the level present in the control cell lines. 'I25I-labeled proteins from two to three independent experiments were quantified by counting excised bands. The amount of pp6Os'rC protein in the tumor cell lines ranged from 0.6 to 2.6 times the amount in normal HCMC. The specific activity of pp60cs was estimated by dividing the total protein kinase activity by the amount of pp60`protein. The specific activity of pp60CSrC from four tumor cell lines (COLO 205, LS 1 74T, LS 180, and HT-29) was higher (four-to sixfold higher as measured by autophosphorylation, or two-to fourfold higher as measured by enolase phosphorylation) than the specific activity of pp6O>src from the normal colonic mucosal cells. Thus, the increase in total pp60>src kinase activity observed in the colon carcinoma cell lines appears to be due both to an increase in the amount of pp60Csrc protein and to an increase in the specific activity of the kinase.
Methods
We also measured the pp605s' protein kinase activity in primary colon carcinomas and adjacent normal mucosa from 21 patients (Fig. 3) . Paired tissue samples of tumor (T) and normal adjacent mucosa (M) from the same patient are shown. The position ofpp6011 or enolase is indicated with an arrow. Three additional proteins of -50, 65, and 80 kD were detected in some lanes. The 50-kD protein is probably rabbit anti-mouse IgG heavy chain. Longer film exposures show that the 65-kD protein was present in all lanes and was more heavily phosphorylated in tumor tissues than in normal mucosa. The 80-kD protein was variably present in both tumor and normal tissue. The total pp60OSn protein kinase activity, as measured either by autophosphorylation or enolase phosphorylation, varied somewhat between normal mucosal samples.
In 13 of 21 patients studied the pp6OC.Src activity in the carcinoma was significantly higher (3-16-fold higher as measured by autophosphorylation, or 2-14-fold higher as measured by enolase phosphorylation) than the activity in the normal mucosa adjacent to the tumor.
pp60 Src protein levels in tissue samples (Fig. 4) Immunoprecipitates were divided into two equal parts, one of which was used for the in vitro protein kinase assay shown in Fig. 1 (Fig. 5) . pp60csrc from the colon carcinoma cell lines COLO 205, LS 1 74T, and HT-29 had the same mobility as pp60(csrc from normal HCMC and as pp6Ocsrc from human fibroblasts (FLOW 2000) . Tryptic digestion of 32P-labeled pp6Ocsrc from human fibroblasts (FLOW 2000) or normal HCMC generated six major phosphopeptides (Fig. 6) Immunoprecipitates were divided into two equal parts, one of which was used for the in vitro protein kinase assay shown in Fig. 3 , the other for immunoblotting as described in the legend to Fig. 2 Colon carcinoma cell lines with elevated pp50C-src in vitro protein kinase activity show increased phosphorylation ofproteins on tyrosine in vivo. To identify substrates ofprotein-tyrosine kinases in colonic cells we used immunoblotting with antibodies to phosphotyrosine. We compared the proteins phosphorylated on tyrosine in colon carcinoma cells with those in normal cells (Fig. 7) . Three phosphotyrosine-containing proteins of -145, 125, and 57 kD were prominent in eight colon carcinoma cell lines (COLO 205, COLO 201, LS 174T, LS 180, WiDr, HT-29, T84, and COLO 396). These three phosphotyrosine-containing proteins were detected at significantly lower levels in the normal HCMC, normal human mammary cells (HBL-100), normal human (FLOW 2000) or rat (208F) fibroblasts, and in three colon carcinoma cell lines (SW 480, HCT-1 5, and COLO 320). We measured the in vitro protein kinase activity of pp60(Csrc from SW 480 cells and observed the activity to be similar to that ofpp6O(-src from normal colonic mucosal cells (Fig. 1) . All colon carcinoma cell lines with elevated pp60Csrc protein kinase activity showed increased tyrosine phosphorylation of the 145-, 125-, and 57-kD proteins. The 57-kD protein is possibly pp6Ocsrc. An additional phosphotyrosine-containing protein of -55 kD was detected in the colon carcinoma cell lines COLO 201, and 205, and may be p56lck (27) . To compare substrates of tyrosine kinases in colon carcinoma cells with substrates of tyrosine kinases in other transformed cells, we analyzed NIH 3T3 cells transformed with DNA from rat neuroblastomas (B104-1-1) (53) for proteins phosphorylated on tyrosine. B104-1-1 cells had increased tyrosine phosphorylation on the 57 but not the 145-or 125-kD proteins. Of note was a phosphotyrosine-containing protein of 110 kD that was present at higher levels in normal cell lines than in most colon carcinoma cell lines.
Discussion
In summary, two-thirds of human colon carcinoma cell lines or tumors contain pp60'>src with elevated in vitro protein-tyrosine kinase activity. The enhanced activity appears to be due both to an increase in the level of pp60csrc protein and to an increase in the specific activity of the pp6Ocsrc kinase. Altered phosphorylation sites on pp60csrc do not appear to contribute to its activation. Colon carcinoma cell lines with elevated pp601>src kinase activity as measured in vitro show increased phosphorylation of proteins on tyrosine in vivo.
Our results are similar to those of Bolen et al. (38) in several ways. First, of seven carcinoma cell lines analyzed in both studies, those with relatively high activity measured in one study had relatively high activity measured in the other (COLO 205, COLO 201, LS 174T, LS 180, WiDr, and HT-29). Conversely, the cell line with relatively low activity measured in one study had relatively low activity measured in the other (SW 480). Second, although the tumors analyzed in the two studies were all different, quantitation oftotal activity, amount of pp6Ocsrc protein, and estimation of specific activity of the pp60>src kinase in the tumors compared with normal mucosa, were very similar in both studies. We found a five-to Our results differ from those of Bolen and co-workers in two ways. One, we observed elevated pp60(-src activity in only two-thirds of carcinoma cell lines and tumors analyzed, whereas they reported enhanced pp60csrc activity in all colon carcinoma cell lines and tumors tested. Two, we measured a five-to eightfold elevation of total pp60csrc activity in colon carcinoma cell lines, whereas they reported a 120-fold elevation in activity. This significant difference is not attributable to small differences in amount of pp60src protein detected in the cell lines in the two studies. The difference may be explained by the level of pp6O-"cs activity recovered from normal colonic mucosal cells. It is possible that there was unusually high pp6Ocsrc activity in the cells we used as controls. However, this seems unlikely because the activity we measured in the normal colonic mucosal cells was not different from that measured in normal human or rodent fibroblasts. Conversely, it is possible that the other group used normal colonic mucosal cells containing unusually low levels of pp60(c activity. Nonetheless, the five-to eightfold increase in pp601src activity that we observed in the carcinoma cell lines was very similar to the fiveto sevenfold increase that we observed in the tumors. In con- trast, Bolen and co-workers reported a 120-fold increase in pp60csrc activity in carcinoma cell lines and a 5-8-fold increase in tumors.
Because colon carcinoma cell lines with elevated pp6011 in vitro kinase activity show increased phosphorylation of proteins on tyrosine in vivo, it is tempting to suggest that pp60/Csrc is an activated tyrosine kinase in colon carcinoma cells. However, ifan activated kinase is present, it could be any one, or more than one, of 30 known mammalian protein-tyrosine kinases, including seven to eight pp60CsrC-related kinases.
Furthermore, the carcinoma cells could contain a reduced level of phosphatase activity in addition to, or instead of an activated protein kinase(s). Of note is the colon carcinoma cell line T84, which has a small increase in pp601rC activity, yet levels of proteins phosphorylated on tyrosine that are indistinguishable from those of cell lines with high pp60(>sr activity. It is possible that in T84 cells the in vitro assay for pp60Cs activity does not accurately reflect its in vivo activity, that the kinase responsible for phosphorylating proteins on tyrosine in vivo is not pp604src, that more than one tyrosine kinase is active, and/or that T84 cells contain lower levels of phosphatases than do other colon carcinoma cell lines.
'
Giordano and co-workers used immunoblotting with antibodies to phosphotyrosine to identify substrates ofendogenous tyrosine kinases in human tumor cell lines (55 (56) (57) (58) , fibroblasts during mitosis (59), and fibroblasts treated with platelet-derived growth factor (60, 61) . However in these cases pp6O`cc has novel phosphorylation sites in the amino-terminal region ofthe molecule that may contribute to its activation.
pp6OC>rC complexed with the middle T antigen in polyoma transformed cells has elevated specific activity compared with free pp60$sc in the same cells (43, 51, 62, 63) , suggesting that association with another protein(s) can regulate pp6Oc$rC activity. However, pp60CSrC from two closely-related colon carcinoma cell lines did not detectably complex with other cellular proteins when analyzed by density gradient centrifuigation or FPLC gel filtration (54) . It remains a possibility that mutations contribute to the activation of c-src in human colon carcinoma.
